Skip to content
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Country/Region
  • No block ID is set

  • Clinic Portal
    • +0034963905310
  • Request Information
  • +34 96 390 53 10
  • Part of brands: |
InternationalInternational
  • Country/Region
  • Part of brands: |
  • Patient Journey
    • Before Pregnancy
    • IVF Process
    • Healthy pregnancy
    • After birth
  • Reproductive Health
    • Specialists
      • ERA
      • ERA insight Hub
      • ALICE
      • EMMA
      • EndomeTRIO
      • Infertility Panels
      • EMBRACE
      • PGT-A
      • PGT-A Plus
      • PGT-M
      • PGT-SR
      • CGT
      • NACE
      • Zenit
      • POC Portfolio
      • SAT
      • Newborn Screening
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
    • Igenomix Worldwide
  • Academy
  • Blog
Genetic Testing Solutions > SAT

SAT Sperm aneuploidy test

Analysis of chromosomal abnormalities in sperm

SAT Sperm aneuploidy test
  • Technical Overview
  • Documentation
  • Scientific evidence
  • I’m not a health specialist
igenomix

Up to 60% of pregnancies miscarry due to sperm chromosomal abnormalities

POC Products of Conception

Results compared with internal control to assure highest reliability

SAT Sperm aneuploidy test

SAT provides personalized genetic counseling to the infertile couple before an IVF treatment

SAT Sperm aneuploidy test

Up to 2,000 spermatozoon analyzed for each chromosome

Interested in learning more?

Request information
Or Email us at supportspain@igenomix.com
Overview
  • SAT
  • Benefits
  • Indications

What is SAT test?

  • The Sperm Aneuploidy Test (SAT) is a test to study the genetic factor of male infertility.
  • It allows for the evaluation of the presence of an abnormal number of chromosomes (aneuploidy and diploidy) in the sperm.
  • The chromosomes 13, 18, 21, X and Y, are most frequently implicated in spontaneous miscarriages and affected offspring with chromosomal abnormalities. In SAT, these chromosomes are analysed by fluorescence in situ hybridization (FISH).

What is the procedure?

SAT Sperm aneuploidy test

Why should use SAT test?

An increase of sperm chromosomal abnormalities affects your reproductive journey at three levels:

SAT Sperm aneuploidy test

EMBRYO LEVEL:

  • Spermatozoa with sex chromosome abnormalities results in aneuploid embryos
  • Diploid sperm results in triploid embryos

Rodrigo et al., 2010.

SAT Sperm aneuploidy test

PREGNANCY LEVEL:

  • An altered SAT decreases pregnancy rate after ICSI and increases miscarriage rate

Rubio et al., 2001.

SAT Sperm aneuploidy test

OFFSPRING LEVEL:

  • Sperm chromosomal abnormalities increase the risk of abnormal offspring for the chromosomes affected in the sperm (Down, Klinefelter or Turner’s Syndromes)
SAT Sperm aneuploidy test

Who should use SAT test?

  • Men with a low sperm concentration, who typically have a higher incidence of sperm chromosome abnormalities
  • Couples who have suffered recurrent miscarriage of unknown origin
  • Couples who have experienced repeated implantation failure
  • Couples with a previous pregnancy with a chromosomal abnormality
SAT Sperm aneuploidy test

Test limitations

This technique allows the detection of aneuploidy only for the chromosomes included in the test (13, 18, 21, X and Y). In very few ejaculated samples or testicular samples, there is not enough spermatozoa for a proper estimation of the risk of aneuploidy.

Documentation
  • SAT Specialists’ documents

Clinical Sheets

Download

Instructions

Download
Scientific evidence

Relevant related studies:

Rodrigo L, Peinado V, Mateu E, Remohí J, Pellicer A, Simón C, Gil-Salom M, Rubio C. Impact of different patterns of sperm chromosomal abnormalities on the chromosomal constitution of preimplantation embryos. Fertil Steril. 2010 Sep; 94(4):1380-6.

Rubio C, Gil-Salom M, Simón C, Vidal F, Rodrigo L, Mínguez Y, Remohí J, Pellicer A. Incidence of sperm chromosomal abnormalities in a risk population: relationship with sperm quality and ICSI outcome. Hum Reprod. 2001 Oct; 16(10):2084-92. 

Rodrigo L, Mateu E, Mercader A, Cobo A, Peinado V, Milán M, Al-Asmar N, Campos-Galindo I, García-Herrero S, Mir P, Simón C, Rubio C. New tools for embryo selection: comprehensive chromosome screening by array comparative genomic hybridization. BioMed
Research International. 2014; In Press. 

FAQs

Opening hours, contact details, lab address...

User manual

If you're a little lost with this technical information...

Can we help you?

I’m not a health specialist

Igenomix and fertility

We work to make a world in which infertility is no longer an impossible barrier. Together with clinics and fertility specialists worldwide, we investigate human reproduction to change the lives of those who are trying to conceive.

Learn more about Igenomix

Other services

PGT-A Preimplantation Genetic Testing

PGT-A

Chromosomally normal
embryos selection

More information

ERA

Evaluates the endometrial receptivity

More information
EndomeTRIO

EndomeTRIO

A new dimension of endometrial health

More information

Igenomix is in the media

WE GUIDE YOU

Fertility
Inherited diseases prevention
Healthy pregnancy

To see the accreditation certificate, associated technical annex and list of accredited tests, click on this link.

OUR SERVICES

Genetic testing solutions
For patients
How to send a sample?
User manual

ABOUT US

About Igenomix
Contact
Quality
Complaints
Work with us
Terms and conditions

FOLLOW IGENOMIX

  + 96 390 53 10
  Write us
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
Country/Region

[2024] © Igenomix Privacy Page Quality policy Legal note Cookies policy

Request Information


  • Patient Journey
    • Before Pregnancy
    • IVF Process
    • Healthy pregnancy
    • After birth
  • Reproductive Health
    • Specialists
      • ERA
      • ERA insight Hub
      • ALICE
      • EMMA
      • EndomeTRIO
      • Infertility Panels
      • EMBRACE
      • PGT-A
      • PGT-A Plus
      • PGT-M
      • PGT-SR
      • CGT
      • NACE
      • Zenit
      • POC Portfolio
      • SAT
      • Newborn Screening
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
    • Igenomix Worldwide
  • Academy
  • Blog
  • Country/Region
  • +34 96 390 53 10
  • Clinic Portal
  • Request Information